These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25034920)

  • 1. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance.
    Edwards NC; Moody WE; Chue CD; Ferro CJ; Townend JN; Steeds RP
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):703-14. PubMed ID: 25034920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac magnetic resonance and uremic cardiomyopathy].
    Di Lullo L; Gorini A; Rivera R; De Pascalis A; Bellasi A; Russo D; Barbera V; Ronco C; Balducci A; Santoboni A
    G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease.
    Edwards NC; Moody WE; Yuan M; Hayer MK; Ferro CJ; Townend JN; Steeds RP
    Am J Cardiol; 2015 May; 115(9):1311-7. PubMed ID: 25769628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study.
    Hayer MK; Radhakrishnan A; Price AM; Liu B; Baig S; Weston CJ; Biasiolli L; Ferro CJ; Townend JN; Steeds RP; Edwards NC;
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2357-2367. PubMed ID: 32682713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease.
    Hayer MK; Price AM; Liu B; Baig S; Ferro CJ; Townend JN; Steeds RP; Edwards NC
    Am J Cardiol; 2018 Mar; 121(5):656-660. PubMed ID: 29366457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes.
    Price AM; Hayer MK; Vijapurapu R; Fyyaz SA; Moody WE; Ferro CJ; Townend JN; Steeds RP; Edwards NC
    BMC Cardiovasc Disord; 2019 Dec; 19(1):295. PubMed ID: 31842769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
    Zoccali C; Mallamaci F; Adamczak M; de Oliveira RB; Massy ZA; Sarafidis P; Agarwal R; Mark PB; Kotanko P; Ferro CJ; Wanner C; Burnier M; Vanholder R; Wiecek A
    Cardiovasc Res; 2023 Sep; 119(11):2017-2032. PubMed ID: 37249051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging.
    Cheang MH; Barber NJ; Khushnood A; Hauser JA; Kowalik GT; Steeden JA; Quail MA; Tullus K; Hothi D; Muthurangu V
    J Cardiovasc Magn Reson; 2018 Mar; 20(1):24. PubMed ID: 29609642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.
    Emans ME; van der Putten K; Velthuis BK; de Vries JJ; Cramer MJ; America YG; Hillege HL; Meiss L; Doevendans PA; Braam B; Gaillard CA
    BMC Cardiovasc Disord; 2012 Sep; 12():76. PubMed ID: 22989293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Magnetic Resonance Imaging of the Myocardium in Chronic Kidney Disease.
    Kis E; Ablonczy L; Reusz GS
    Kidney Blood Press Res; 2018; 43(1):134-142. PubMed ID: 29444516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
    Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H
    Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Magnetic Resonance Imaging Findings in Patients With Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.
    Chandramohan D; Rajasekaran R; Konda R; Pujari A; Avula S; Bell M; Palleti SK; Deotare A; Naik R; Bali A; Simhadri P; Arora H; Jena N
    Cureus; 2024 Jan; 16(1):e51672. PubMed ID: 38313918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease.
    Parnham S; Gleadle JM; Bangalore S; Grover S; Perry R; Woodman RJ; De Pasquale CG; Selvanayagam JB
    J Am Heart Assoc; 2015 Aug; 4(8):e002249. PubMed ID: 26260054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
    Nguyen TD; Schulze PC
    Circ Res; 2023 Apr; 132(8):1034-1049. PubMed ID: 37053280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
    Rutherford E; Talle MA; Mangion K; Bell E; Rauhalammi SM; Roditi G; McComb C; Radjenovic A; Welsh P; Woodward R; Struthers AD; Jardine AG; Patel RK; Berry C; Mark PB
    Kidney Int; 2016 Oct; 90(4):845-52. PubMed ID: 27503805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
    Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.
    Patel RK; Mark PB; Halliday C; Steedman T; Dargie HJ; Cobbe SM; Jardine AG
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):519-27. PubMed ID: 21088291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the kisspeptin-KISS1R axis in the pathogenesis of chronic kidney disease and uremic cardiomyopathy.
    Dinh H; Kovács ZZA; Kis M; Kupecz K; Sejben A; Szűcs G; Márványkövi F; Siska A; Freiwan M; Pósa SP; Galla Z; Ibos KE; Bodnár É; Lauber GY; Goncalves AIA; Acar E; Kriston A; Kovács F; Horváth P; Bozsó Z; Tóth G; Földesi I; Monostori P; Cserni G; Podesser BK; Lehoczki A; Pokreisz P; Kiss A; Dux L; Csabafi K; Sárközy M
    Geroscience; 2024 Apr; 46(2):2463-2488. PubMed ID: 37987885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.